Maravai Lifesciences Holdings, Inc.
(NASDAQ : MRVI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Commercial Services » Miscellaneous Commercial Services
symbolcompany%chnglast%shortavg$volume
ETSYEtsy, Inc. -7.31%231.337.5%$638.81m
EFXEquifax, Inc. -2.93%282.472.0%$192.71m
CHGGChegg, Inc. -1.31%28.5713.1%$186.04m
FLTFLEETCOR Technologies, Inc. 0.09%208.063.7%$147.05m
CRLCharles River Laboratories International, Inc. -2.32%357.474.5%$142.89m
CPRTCopart, Inc. -0.95%145.624.4%$137.69m
ADGIAdagio Therapeutics, Inc. -1.42%45.830.0%$128.26m
CLVTClarivate Plc -6.74%23.520.0%$106.78m
PSFEPaysafe Ltd. -6.77%3.380.0%$102.21m
FOURShift4 Payments, Inc. -2.84%51.000.0%$95.59m
TALTAL Education Group -8.98%4.560.7%$89.42m
BKKTBakkt Holdings, Inc. -6.66%13.030.0%$88.61m
MRVIMaravai Lifesciences Holdings, Inc. -2.05%42.150.0%$82.19m
PAGSPagSeguro Digital Ltd. -5.78%24.800.0%$77.20m
SYNHSyneos Health, Inc. -1.44%97.230.0%$70.18m

Company Profile

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics,and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers’ research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The Protein Detection segment is engaged in manufacturing and selling labeling and visual detection reagents to scientific research customers for their tissue-based protein detection and characterization needs. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.